Oklo (OKLO) is back in focus after the U.S. Department of Energy approved the Documented Safety Analysis for its Groves Isotope Test Reactor in Texas, highlighting both regulatory progress and ongoing early stage risks.

Oklo's latest safety milestone comes after a volatile stretch, with the 1 day share price return of 4.21% at US$49.27 contrasting with a weaker year to date share price return that is down 36.67%. The 5 year total shareholder return is up by a very large amount, suggesting long term momentum remains influential despite recent pullbacks and index rebalancing noise.

If Oklo's early stage nuclear story has your attention, it can be useful to compare it with other nuclear infrastructure opportunities by reviewing the 89 nuclear energy infrastructure stocks

Oklo now has a big regulatory win and a long pipeline of power and isotope ambitions, yet the stock has pulled back sharply this year. The question for investors is how much of that future is already baked into today’s US$49.27 price?

Most Popular Narrative: 38.8% Undervalued

Oklo’s most followed valuation story pegs fair value at about $80.55 per share, which sits well above the last close of $49.27 and frames today’s pullback in a very different light.

Oklo is another modular / small nuclear reactor maker, calling them Aurora Powerhouses. But it is not trying to sell reactors; it is trying to sell long-term electricity contracts while maintaining ownership of the plants. We are talking recurring, predictable revenue, not just selling equipment. Obviously, AI data centers are at play here. That is a significant tailwind. 

Want to see why this valuation leans so heavily on future contracts, not current revenue? The narrative leans on aggressive top line growth, margin expansion, and a premium future earnings multiple usually reserved for established utilities with strong visibility.

Result: Fair Value of $80.55 (UNDERVALUED)

However, Oklo still has key pressure points, including no commercial plants in operation and ongoing net losses that could challenge the narrative that it is 38.8% undervalued.

Next Steps

If this mix of optimism and concern around Oklo leaves you undecided, consider acting promptly and weigh the trade off yourself by reviewing the 1 key reward and 5 important warning signs

Looking for more investment ideas beyond Oklo?

Do not stop with Oklo; broaden your watchlist now so you are not relying on a single early stage story when there are other compelling setups.

• Target potential value opportunities by scanning 44 high quality undervalued stocks and see which stocks currently line up with stronger fundamentals.
• Strengthen your focus on resilience by reviewing the 73 resilient stocks with low risk scores that screens for companies with lower overall risk profiles.
• Spot companies flying under the radar by checking the screener containing 19 high quality undiscovered gems that filters for quality businesses the crowd may be overlooking.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.